NIFTY 50

Dr Reddy's share plunge 4.17 percent on NSE after analysts raise concerns over USFDA observations

Updated : February 15, 2019 03:38 PM IST

Dr Reddy's shares fell as much as 23.6 percent to Rs 1,872.95 per share on the NSE
USFDA had completed an inspection at the company’s formulation facility at Bachupally, Hyderabad, and had issued 11 observations.
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV